{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:45:44Z","timestamp":1759041944685},"reference-count":26,"publisher":"Scientific Scholar","content-domain":{"domain":["surgicalneurologyint.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec id=\"st1\"><jats:title>Background:<\/jats:title><jats:p>Suicide cases are the end product of a combination of biological, clinical, psychological, social, and cultural risk\/protective factors, and attempts to remain unpredictable.<\/jats:p><\/jats:sec><jats:sec id=\"st2\"><jats:title>Case Description:<\/jats:title><jats:p>A 43-year-old male presented to the hospital with jaundiced skin\/eyes of 7 days\u2019 duration. He had a history of a major depressive disorder and chronic alcohol consumption (e.g., 3\u20135 alcoholic drinks\/day for the past 15 years). Studies documented acute hepatic disease (e.g., biopsy-documented hepatocellular alcoholic hepatitis), accompanied by a cholestatic disease. The patient was discharged on clonidine, iron multivitamin, folic acid, gabapentin, and prednisone. Eight days postdischarge from the hospital, he committed suicide (e.g., self- inflicted gunshot wound to the head).<\/jats:p><\/jats:sec><jats:sec id=\"st3\"><jats:title>Conclusion:<\/jats:title><jats:p>Concomitant administration of gabapentin, prednisone, and clonidine, especially if used for the first time, may play a synergistic effect in increasing a patient\u2019s suicide risk.<\/jats:p><\/jats:sec>","DOI":"10.25259\/sni_58_2020","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T09:15:02Z","timestamp":1583486102000},"page":"41","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SNI case of the week: Initial concomitant use of gabapentin, clonidine, and prednisone may enhance suicidal ideation: A case report"],"prefix":"10.25259","volume":"11","author":[{"given":"Ramsis F.","family":"Ghaly","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, United States"},{"name":"Ghaly Neurosurgical Associates, Aurora, Illinois, United States."},{"name":"Department of Anesthesiology, University of Illinois, Chicago, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Plesca","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth D.","family":"Candido","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, United States"},{"name":"Department of Anesthesiology, University of Illinois, Chicago, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nebojsa Nick","family":"Knezevic","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Advocate Illinois Masonic Medical Center, Chicago, United States"},{"name":"Department of Anesthesiology, University of Illinois, Chicago, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"key":"10.25259\/SNI_58_2020\/ref-1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1176\/ajp.153.8.1009","article-title":"Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: A case-control study","volume":"153","author":"Beautrais","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.25259\/SNI_58_2020\/ref-2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ajmg.c.30041","article-title":"Suicidal behavior prevention: WHO perspectives on research","volume":"133C","author":"Bertolote","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.25259\/SNI_58_2020\/ref-3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/alcalc\/agp085","article-title":"An open trial of gabapentin in acute alcohol withdrawal using an oral loading protocol","volume":"45","author":"Bonnet","year":"2010","journal-title":"Alcohol Alcohol"},{"key":"10.25259\/SNI_58_2020\/ref-4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.7326\/0003-4819-93-3-456","article-title":"Clonidine hallucinations","volume":"93","author":"Brown","year":"1980","journal-title":"Ann Intern Med"},{"key":"10.25259\/SNI_58_2020\/ref-5","first-page":"45","article-title":"Clonidine hallucinations: Description of a clinical case","volume":"151","author":"Campanella","year":"2000","journal-title":"Clin Ter"},{"key":"10.25259\/SNI_58_2020\/ref-6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00414-015-1193-3","article-title":"An acute gabapentin fatality: A case report with postmortem concentrations","volume":"129","author":"Cantrell","year":"2015","journal-title":"Int J Legal Med"},{"key":"10.25259\/SNI_58_2020\/ref-7","doi-asserted-by":"crossref","first-page":"9087","DOI":"10.1523\/JNEUROSCI.2928-08.2008","article-title":"Anxious to drink: Gabapentin normalizes GABAergic transmission in the central amygdala and reduces symptoms of ethanol dependence","volume":"28","author":"Clemens","year":"2008","journal-title":"J Neurosci"},{"key":"10.25259\/SNI_58_2020\/ref-8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijcard.2005.09.032","article-title":"Clonidine-induced delirium","volume":"113","author":"Delaney","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.25259\/SNI_58_2020\/ref-9","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1185\/03007997709115290","article-title":"Acute hallucinosis due to clonidine","volume":"4","author":"Enoch","year":"1977","journal-title":"Curr Med Res Opin"},{"key":"10.25259\/SNI_58_2020\/ref-10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1176\/appi.ajp.2011.11071009","article-title":"Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care","volume":"169","author":"Fardet","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.25259\/SNI_58_2020\/ref-11","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4103\/sni.sni_420_17","article-title":"Gabapentin-related suicide: Myth or fact?","volume":"9","author":"Ghaly","year":"2018","journal-title":"Surg Neurol Int"},{"key":"10.25259\/SNI_58_2020\/ref-12","doi-asserted-by":"crossref","first-page":"e1002396","DOI":"10.1371\/journal.pmed.1002396","article-title":"Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study","volume":"14","author":"Gomes","year":"2017","journal-title":"PLoS Med"},{"key":"10.25259\/SNI_58_2020\/ref-13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1535-7511.2010.01382.x","article-title":"An update on antiepileptic drugs and suicide: Are there definitive answers yet?","volume":"10","author":"Hesdorffer","year":"2010","journal-title":"Epilepsy Curr"},{"key":"10.25259\/SNI_58_2020\/ref-14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.31887\/DCNS.2007.9.1\/jchuffman","article-title":"Neuropsychiatric consequences of cardiovascular medications","volume":"9","author":"Huffman","year":"2007","journal-title":"Dialogues Clin Neurosci"},{"key":"10.25259\/SNI_58_2020\/ref-15","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1176\/appi.ajp.2014.13091264","article-title":"Adverse consequences of glucocorticoid medication: Psychological, cognitive, and behavioral effects","volume":"171","author":"Judd","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.25259\/SNI_58_2020\/ref-16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-clinpsy-021815-093204","article-title":"Suicide, suicide attempts, and suicidal ideation","volume":"12","author":"Klonsky","year":"2016","journal-title":"Annu Rev Clin Psychol"},{"key":"10.25259\/SNI_58_2020\/ref-17","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/liv.12612","article-title":"Major depression and suicide attempts in patients with liver disease in the United States","volume":"35","author":"Le Strat","year":"2015","journal-title":"Liver Int"},{"key":"10.25259\/SNI_58_2020\/ref-18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/1060028015585849","article-title":"The role of gabapentin in the management of alcohol withdrawal and dependence","volume":"49","author":"Leung","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.25259\/SNI_58_2020\/ref-19","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/j.1556-4029.2011.01798.x","article-title":"Suicide by gabapentin overdose","volume":"56","author":"Middleton","year":"2011","journal-title":"J Forensic Sci"},{"key":"10.25259\/SNI_58_2020\/ref-20","doi-asserted-by":"crossref","first-page":"l2147","DOI":"10.1136\/bmj.l2147","article-title":"Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: Population based cohort study in Sweden","volume":"365","author":"Molero","year":"2019","journal-title":"BMJ"},{"key":"10.25259\/SNI_58_2020\/ref-21","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1530-0277.2009.00986.x","article-title":"A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal","volume":"33","author":"Myrick","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"key":"10.25259\/SNI_58_2020\/ref-22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0165-0327(95)00025-I","article-title":"GABA and mood disorders: A brief review and hypothesis","volume":"34","author":"Petty","year":"1995","journal-title":"J Affect Disord"},{"key":"10.25259\/SNI_58_2020\/ref-23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.revmed.2012.12.011","article-title":"Oral glucocorticoid-induced psychiatric side-effects: Focus on clinical specificities, incidence, risk factors and treatment","volume":"34","author":"Ricoux","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.25259\/SNI_58_2020\/ref-24","article-title":"Suicide Data"},{"key":"10.25259\/SNI_58_2020\/ref-25","article-title":"Suicide Statistics"},{"key":"10.25259\/SNI_58_2020\/ref-26","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/10401239909147074","article-title":"Anabolic androgenic steroids and suicide","volume":"11","author":"Thiblin","year":"1999","journal-title":"Ann Clin Psychiatry"}],"container-title":["Surgical Neurology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/surgicalneurologyint.com\/sni-case-of-the-week-initial-concomitant-use-of-gabapentin-clonidine-and-prednisone-may-enhance-suicidal-ideation-a-case-report\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/sni-case-of-the-week-initial-concomitant-use-of-gabapentin-clonidine-and-prednisone-may-enhance-suicidal-ideation-a-case-report\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T21:52:28Z","timestamp":1614721948000},"score":1,"resource":{"primary":{"URL":"http:\/\/surgicalneurologyint.com\/surgicalint-articles\/sni-case-of-the-week-initial-concomitant-use-of-gabapentin-clonidine-and-prednisone-may-enhance-suicidal-ideation-a-case-report\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":26,"alternative-id":["10.25259\/SNI_58_2020"],"URL":"https:\/\/doi.org\/10.25259\/sni_58_2020","relation":{},"ISSN":["2152-7806"],"issn-type":[{"value":"2152-7806","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"article-number":"41"}}